Hemorragia subaracnoidea. Malformaciones arteriovenosas

  1. Cadavid, M. Santamaría
  2. Rivas, S. Arias
  3. Yáñez, M. Rodríguez
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2019

Serie: 12

Número: 70

Páginas: 4097-4107

Tipo: Artículo

DOI: 10.1016/J.MED.2019.01.003 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

Resumen La hemorragia subaracnoidea es la extravasación de sangre al espacio subaracnoideo. Las causas más frecuentes son los traumatismos craneoencefálicos y la rotura de aneurismas cerebrales. El síntoma de presentación más frecuente es la cefalea en trueno, aislada o asociada a síntomas focales. En cuanto al tratamiento, se recomienda el cierre precoz del aneurisma roto mediante cirugía o mediante tratamiento endovascular para evitar el resangrado. También es importante el tratamiento de las complicaciones como vasoespasmo, crisis comiciales, isquemia cerebral diferida o complicaciones médicas (hiponatremia, fiebre, etc.). Las malformaciones arteriovenosas son anormalidades de los vasos sanguíneos cerebrales, en los que se producen conexiones directas entre las arterias y las venas a través de un ovillo de vasos dilatados (nidus). Los síntomas más frecuentes son los focales por hemorragia cerebral, crisis comiciales o déficits neurológicos progresivos. Su tratamiento se puede llevar a cabo mediante cirugía, tratamiento endovascular o radiocirugía.

Referencias bibliográficas

  • Andreasen TH, Bartek J Jr, Andresen M, Springborg JB, Romner B. Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 2013; 44:3607-12.
  • Blackburn SL, Ashely WW, Rich KM, Simpson JR, Drzumala RE, Ray WZ. Combined endovascular embolization and sterotatic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg. 2011;114:1758-67.
  • Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage. The Fisher scale revisited. Stroke. 2001;32:2012-20.
  • Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart As-sociation / american P Stroke Association.Stroke. 2012;43:1711-37.
  • De Rooij NK, Linn FH, var der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoide haemorrhage: a systematic review with emphasis on región, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365-72.
  • Deyden CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP. Management of brain arteriovenous malformations. A scientific statement for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2017;48:200-24.
  • Ding D, Yen CP, Starke RM, Xu Z, Sun X, Sheehan JP. Outcomes following single session radiosurgery for high grade intracranial arteriovenous malformations. Br J Neurosurg. 2014;28:666-74.
  • Dodick DW. Thunderclap headache. J Neurol Neurosurg Psychiatry. 2002;72:6-11.
  • Drake CG. Report of World Federation of Neurosurgical Surgeons Committee on a universal SAH grading scale. J Neurosurg. 1988;68:985-6.
  • Edlow JA. Diagnosis of subarachnoid hemorrhage. Neurocrit Care. 2005;2:99-109. Fisher CM, Kitsler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980:6:1-9.
  • Frielander RM. Arteriovenous malformations of the brain. N Engl J Med. 2007;356:2704-12.
  • Greving JP, WemerMJ, Brown RD Jr, Morita A4, Juvela S5, Yonekura M. Development of the PHASES score for prediction of risk ruptura of intracranial aneurysms: a pooled analysIs of six prospective cohort studies. Lancet Neurol. 2014;13:59-66.
  • Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformations. Stroke. 1998; 29:303-9.
  • Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly TJr, Stewart CL. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery. 2004;54:410-23.
  • Heros RC, Korosue K, Diebold PM. Surgical excision of cerebral arteriovenous malformations. Neurosurgery. 1990;26:570-7.
  • Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 1968;28:14-20.
  • Inamasu J, Nakamura Y, Saito R, Horoguchi T, Kuroshima Y, Mayanagi K. “Occult” ruptured cerebral aneurysms revealed by repeat angiography: results from a large retrospective study. Clin Neurol Neurosurg. 2003;106:33-7.
  • Josephson CB, White PM, Krishan A, Al-Shahi Salman R. Compute tomography angiography or magnetic resonance angiography for the detecion of intracranial vascular malformations in patiens with intracerebral hemorrhage. Cochrane Database Syst Rev. 2014;9:CD009372.
  • Kitsler JP, Crowell RM, Davis KR. The relation of cerebral vasospam to extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology. 1983;33:424-36.
  • Li H, Pan R, Wang H, Rong X, Yin Z, Milgrom DP. Clipping versus coiling for ruptured intracranial aneurysms: a systematic review and meta-analysis. Stroke. 2013;44(1):29-37.
  • Macdonald RL, Schweizer TA. Spontaneus subarachnoid haemorrhage. Lancet. 2017,389:665-6.
  • Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey KR. Medical management with or without interventional therapy for unruptured brain arteriovenous mal-formations (ARUBA): a multicentre, non blinded randomised trial. Lancet. 2014;383:614-21.
  • Njeuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rikel GJ. Changes in the case fatality of aneurysmal subarachnoid haemorrhage over time, accordin to age, sex, and región: a meta-analysis. Lancet Neu-rol. 2009;8:635-42.
  • Solomon RA, Connolly S. Arteriovenous malformations of the brain. N Eng J Med. 2017;11:1859-66.
  • Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476-83.
  • Starke RM, Yen CP, Chen CJ, Ding D, Mmohila CA, Jensen ME. An updated assesment of the risk of radiation induced neoplasia after readiosurgery of arteriovenous malformations. World Neurosurg. 2014; 82:395-401.
  • Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93-112.
  • Tanabey S, Uede T, Nonaka T, Ohtaki M, Hashi K. Diagnosis of cerebral arteriovenous malformations wih three dimensional CT angiography. J Clin Neurosci. 1998;5:33-8.
  • Van der Schaaf IC, Velthuis BK, Gouw A, Rinkel GE. Venous drainage in perimesencephalic hemorrhage. Stroke. 2004;35:1614-8.
  • Vivancos J, Gilo F, Frutos R, Maestre J, García-Pastor A, Quintana F. Guía de actuación clínica en la hemorragia subaracnoidea. Sistemática diagnóstica y tratamiento. Neurología. 2014;29(6): 353-70.
  • Westerlaan HE, Van Dijk JM, Janser-van der Weide MC, de Groot JC, Groen RJ, Mooij JJ. Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis: a systematic review and meta-analysis. Radiology. 2011;258: 134-45.
Fuente de los datos: Dialnet